Corporate VCs pick up some slack in biotech; Dendreon's Provenge data blasted again;

Conversation on Twitter :

 @FierceBiotech: Alzheimer's drug builds new brain cell connections in rats. Story | Follow @FierceBiotech

 @JohnCFierce: New FDA lung cancer OK for Celgene's Abraxane should boost sales. More | Follow @JohnCFierce

 @RyanMFierce: Biotech regulars should appreciate this. Actress Jennifer Aniston investing in a Bob Langer company. More | Follow @RyanMFierce

> Large pharma and biotech companies' venture units have stepped up investments in drug developers as some traditional VC groups step back from the risky bets. Nature article

> Lexicon Pharmaceuticals ($LXRX) has launched a Phase III trial for an experimental drug against carcinoid syndrome. Release

> Reuters reports that a different way of analyzing data on Dendreon's ($DNDN) prostate cancer drug Provenge could have boosted the apparent benefits. Article

> Pfizer ($PFE) revealed that ALO-02, an experimental pain drug, appeared as safe as existing formulations in a Phase III study. Item

> Novartis ($NVS) has dropped development of a long-acting antipsychotic drug known as Fanapt from Vanda Pharmaceuticals. Report

Pharma News

@FiercePharma: How is the U.K.'s fund for NICE-nixed cancer drugs faring? Total spent since 10/2010: £180.9M on 18K+ patients. Report | Follow @FiercePharma

> Novartis, Sanofi unveil data backing their rival MS pills. Story

> New FDA lung cancer OK for Celgene's Abraxane should boost sales. Article

> Pfizer aims to keep CEO off the stand in Chantix trial. News

Medical Device News

 @FierceMedDev: Coming soon: we'll find out if Intuitive Surgical's earnings slowed in Q3 as predicted. Let the speculation begin. More | Follow @FierceMedDev

 @MarkHFierce: Medtech industry's efficiency reaches new level, PWC report concludes. Article | Follow @MarkHFierce

 @DamianFierce: A federal court has tossed Fresenius' $83M Medicare fraud judgement. More  | Follow @DamianFierce

> FDA approves aortic-repair stent grafts. Article

> As it turns to medtech, Sony's credit rating gets lowered. Report

> Observers watch Intuitive Surgical closely for Q3 clues. Story

And Finally… The now notorious New England Compounding, which has been linked with a meningitis scare, faces its first patient lawsuit. Item

Suggested Articles

Myovant’s uterine fibroid drug reduced blood loss in nearly three-quarters of patients, trouncing placebo in the second of two phase 3 studies.

The cystic fibrosis biotech unveiled Belous’ appointment alongside news of the promotion of Geoff Gilmartin to the CMO position.

The series C round is the latest in a series of boosts for Frequency’s attempts to tackle hearing loss through the activation of progenitor cells.